Clinical trial of the efficacy of pegylated interferon (PEG-IFNalpha-2a) [peginterferon-alpha-2a] alone in Egyptian patients with acute hepatitis C

Trial Profile

Clinical trial of the efficacy of pegylated interferon (PEG-IFNalpha-2a) [peginterferon-alpha-2a] alone in Egyptian patients with acute hepatitis C

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2008

At a glance

  • Drugs Peginterferon alfa-2a (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Feb 2008 Status changed from recruiting to completed.
    • 12 Oct 2007 The expected completion date for this trial is now 1 Nov 2007.
    • 18 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top